← Leaderboards
Juliann B Burkett
Vanderbilt University
$69,064
Attributed
$69,064
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $34.8K · FY2024–25$50K$37.5K$25K$12.5K$0
'24
'25
Funding mix
By agency
NIH$69,064 · 1
By mechanism
F31$69,064 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Richard M Breyer$8,994,550
- William M Grady$22,313,396
- Claus Schneider$9,629,126
- James Ward Thomas$11,948,664
- Matthew Douglas Breyer$9,196,649
Others in their field
Other Rising Stars on “Affinity”
- Jason Dickens · Duke University$12,259,409
- Jeff T Hutchins · Inhalon Biopharma, Inc.$8,734,904
- Joseph Fraser Glickman · Hackensack University Medical Center$8,363,749
- Mark Sorenson · Nirsum Laboratories, Inc.$4,866,388
- Michael P Weiner · Abbratech, Inc.$4,404,422
- Moustafa Gabr · Weill Medical Coll Of Cornell Univ$3,945,669
Research focus
AffinityAntagonistAntioxidantsAttenuatedAutoimmuneAutoimmune DiseasesAutoimmune InflammationAutoimmune PathogenesisAutoimmunityAutophagocytosisAutoreactivityBeta CellBiological Adaptation To StressBlood GlucoseCell DeathCell PhysiologyCell ProliferationCellsCell SurvivalCellular StressChronicClinical TrialsCouplesAffect
Grant awards (2)
Targeting the Opposing Roles of Prostaglandin E2 Receptors, EP3 and EP4, in the Pathogenesis of Type One Diabetes$34,814
F31 · FY2025 · DK · contact PI
Targeting the Opposing Roles of Prostaglandin E2 Receptors, EP3 and EP4, in the Pathogenesis of Type One Diabetes$34,250
F31 · FY2024 · DK · contact PI